The 20 Best Brain Stem Cancer Doctors Near Me in Ypsilanti, MI

Paul Arpasi is an Interventional Radiologist practicing medicine in Ypsilanti, Michigan. Dr. Arpasi is rated as an Experienced provider by MediFind in the treatment of Brain Stem Cancer. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Familial Prostate Cancer, Bone Marrow Aspiration, and Bone Graft.

Dr. Wajd Al-Holou was raised in southeast Michigan. After attending the University of Michigan Medical School, where he graduated with the highest award for research, he then began a 7-year Neurosurgery residency at the University of Michigan. Upon completion of residency in 2016, he completed a Complex Neurosurgical Oncology Fellowship at the MD Anderson Cancer Center in Houston, TX. His training focused on the management of complex brain tumors, spinal tumors, and skull base malignancies.Dr. Al-Holou specializes in the management of complex brain tumors, primarily focusing on gliomas and metastases to the brain. Dr. Al-Holou has expertise in the use of awake mapping techniques, microsurgery, and image-guidance to maximize tumor removal in the safest possible manner. He also specializes in the management of meningiomas and spinal tumors.Dr. Al-Holou is the co-founder and co-director of the Michigan Medicine Multidisciplinary Brain Tumor Clinic (M3BTC). As a member of this Neuro-Oncology multidisciplinary team, he works strategically to ensure personalized treatment recommendations that will maximize the benefits for each individual patient.Currently, he is a member of the AANS/CNS Executive Committee of the Section on Tumors. He served as the Co-Chair for Tumor Section Scientific Program for the American Association of Neurological Surgeons (AANS) in 2018 and is a member of the Society of Neuro-Oncology. He also serves as an editor for cancer journal, BMC Cancer.Dr. Al-Holou is committed to research and education in Neurosurgery and his life-long goal is improving the survival and outcomes for patients with tumors. His research interest focuses primarily on understanding the genetic mechanisms of recurrence in glioblastoma, and in identifying precision medicine therapies to target resistant tumors. Dr. Al is rated as a Distinguished provider by MediFind in the treatment of Brain Stem Cancer. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Primitive Neuroectodermal Tumor (PNET), Posterior Fossa Tumor, Astrocytoma, Oligodendroglioma, and Awake Craniotomy. Dr. Al is board certified in Neurological Surgery.

David Altshuler is a Neurosurgery provider practicing medicine in Ann Arbor, Michigan. Dr. Altshuler is rated as a Distinguished provider by MediFind in the treatment of Brain Stem Cancer. He is also highly rated in 48 other conditions, according to our data. His clinical expertise encompasses Pituitary Tumor, Rathke Cleft Cyst, Craniopharyngioma, Awake Craniotomy, and Extracranial-Intracranial Bypass Surgery.

Dr. Wahl is a physician scientist at the University of Michigan specializing in cancers of the central nervous system. His research focuses on the development of new treatment strategies for brain tumors and his laboratory group is especially interested in interactions between radiation and abnormal metabolism in glioblastoma. In the clinic, he cares for a wide variety of patients with both malignant and benign tumors of the central nervous system. Dr. Wahl is rated as a Distinguished provider by MediFind in the treatment of Brain Stem Cancer. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Glioblastoma, Astrocytoma, Glioma, and Brain Tumor.

Dr. Mihaylova was born and raised in Bulgaria where she completed Medical School at the University of Sofia in 1997. Subsequently she extended her training into a three-year post-doctoral program and conducted clinical research on newly diagnosed epilepsy patients. She was granted her PhD degree in 2002. Since then she has been living in the US where she completed her Neurology residency at Wayne State University followed by a year of fellowship training in Clinical Neurophysiology with emphasis on Epilepsy/EEG at the same institution. Her primary clinical and research interests involve the treatment of medically intractable epilepsy including VNS and surgical treatment, EEG analysis and seizure semiology. Dr. Mihaylova is rated as an Advanced provider by MediFind in the treatment of Brain Stem Cancer. She is also highly rated in 24 other conditions, according to our data. Her clinical expertise encompasses Seizures, Autosomal Dominant Nocturnal Frontal Lobe Epilepsy (ADNFLE), Generalized Tonic-Clonic Seizure, and Partial Seizure. Dr. Mihaylova is board certified in Neurology, Clinical Neurophysiology, and Epilepsy.

Dr. Koschmann is a Pediatric Neuro-Oncologist in the Department of Pediatrics and a Principal Investigator of an independent translational Pediatric Neuro-Oncology laboratory. His work in the clinic and lab complement and drive each other, resulting in a clear goal to improve therapies for children with brain tumors. He has engaged in research and the clinical care of pediatric brain tumor patients at both Seattle Children’s Hospital and the University of Michigan’s Mott Children’s Hospital. The Koschmann laboratory is exploring the molecular mechanisms by which recurrent mutations in pediatric high-grade glioma (HGG), including glioblastoma (GBM), anaplastic astrocytoma (AA) and diffuse intrinsic pontine glioma (DIPG) promotes tumor formation and affect treatment response.Dr. Koschmann has applied this precision medicine approach in translational and clinical work in Pediatric Neuro-Oncology. Along with researchers and colleagues from multiple clinical divisions at the University of Michigan and other institutions, he developed and co-facilitate the UM CNS Precision Medicine conference. In this multi-disciplinary and multi-institutional conference, molecular results are incorporated from pediatric brain tumor patients (paired tumor/germline sequencing results and pre-clinical cell culture treatment studies) into their treatment. Dr. Koschmann has established new algorithms and are in the process of developing multiple clinical trials incorporating the use of molecularly targeted therapy for pediatric patients with brain tumors. He will serve as PI for these trials and their biologic correlative research. Dr. Koschmann is rated as a Distinguished provider by MediFind in the treatment of Brain Stem Cancer. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Diffuse Midline Glioma H3 K27M-Mutant, Glioma, Brain Stem Cancer, and Embryonal Tumor with Multilayered Rosettes. Dr. Koschmann is board certified in Pediatric Hematology-Oncology and Pediatrics.

Dr. Patricia Robertson, M.D., earned a medical degree at Wayne State University Medical School in Detroit and completed a residency in pediatrics at Children's Hospital of Michigan. She then went on to a fellowship in pediatric neurology at the University of Michigan and trained in pediatric neuro-oncology at New York University Medical Center. Dr. Robertson joined the University of Michigan faculty in 1988. She has a special interest in clinical pediatric neuro-oncology focusing on the evaluation of response, outcome and late effects on the developing nervous system; current treatment strategies for children with central nervous malignancies; and in the development of innovative treatment approaches for this population. Dr. Robertson is rated as a Distinguished provider by MediFind in the treatment of Brain Stem Cancer. She is also highly rated in 42 other conditions, according to our data. Her clinical expertise encompasses Glioma, Diencephalic Syndrome, Brain Stem Cancer, and Brain Tumor.

Eva Bieniek is a Radiation Oncologist practicing medicine in Ypsilanti, Michigan. Dr. Bieniek is rated as an Experienced provider by MediFind in the treatment of Brain Stem Cancer. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Posterior Fossa Tumor, Lung Cancer, Pleuropulmonary Blastoma, and Endometrial Cancer.

Geoffrey Thomas is a Neurosurgery provider practicing medicine in Ypsilanti, Michigan. Dr. Thomas is rated as an Experienced provider by MediFind in the treatment of Brain Stem Cancer. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Meningioma, Radiation Induced Meningioma, Spondylolisthesis, Septoplasty, and Bone Graft.

Jason Brodkey is a Neurosurgery provider practicing medicine in Ypsilanti, Michigan. Dr. Brodkey is rated as an Experienced provider by MediFind in the treatment of Brain Stem Cancer. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Cervical Spondylosis, Spondylolisthesis, Spinal Stenosis, Microdiscectomy, and Herniated Disc Surgery.

Jayesh Thawani is a Neurosurgery provider practicing medicine in Ypsilanti, Michigan. Dr. Thawani is rated as an Experienced provider by MediFind in the treatment of Brain Stem Cancer. He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Subdural Hematoma, Chronic Subdural Hematoma, Metastatic Brain Tumor, Laminectomy, and Awake Craniotomy.

Simon Glynn is a Neurologist practicing medicine in Ann Arbor, Michigan. Dr. Glynn is rated as an Advanced provider by MediFind in the treatment of Brain Stem Cancer. He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Seizures, Memory Loss, Autosomal Dominant Partial Epilepsy with Auditory Features, and Epilepsy. Dr. Glynn is board certified in Neurology and Epilepsy.

Dr. B. Gregory Thompson was born in Kansas City, Missouri, the oldest son in a family of eleven children. Dr. Thompson attended Harvard College, where he played football and studied English and biology. He graduated from the University of Kansas School of Medicine and subsequently entered neurosurgery residency training at the University of Pittsburgh, where he did elective rotations in neurology at Queen Square in London, England, and as a Medical Staff Research Fellow at the National Institutes of Health in Bethesda, Maryland.Following his residency in Pittsburgh, Dr. Thompson did a neurovascular and skull base surgery fellowship at the Barrow Neurological Institute and began his academic career at the University of Utah. He was then recruited to the University of Michigan.After 10 years in practice, Dr. Thompson recognized that the rapid technological and clinical development of interventional neuroradiology was a force rapidly changing cerebrovascular surgery and training, and so he returned to training as a fellow in Endovascular Neurological Surgery (ENS) at Thomas Jefferson University in Philadelphia.Upon returning full time to the University of Michigan in 2005, he became Vice Chairman of the Neurosurgery Department and established a curriculum for neurosurgery resident education in ENS. He also subsequently established a “dual training” cerebrovascular fellowship which encompasses both endovascular and advanced microsurgical techniques.Working also with a cranial base team of six otologists at Michigan, Dr Thompson has operated more than 1,000 patients with vestibular schwannomas, and their Michigan team has reported significantly improved hearing preservation results with the Middle Fossa Approach.Dr. Thompson received the University of Michigan’s Medical Student Award for Teaching Excellence in Neuroscience, the University’s Outstanding Clinician Award, and was an inaugural member of the University’s League of Clinical Excellence. He was honored with the Cerebrovascular Section’s Alfred J. Luessenhop Award in Cerebrovascular Surgery in 2011, and was appointed as a Director of the American Board of Neurological Surgery in 2012. He currently serves as the Chair of the ABNS. Dr. Thompson and his wife Ramona have 7 children and reside in Ann Arbor.50813181. Dr. Thompson is rated as an Advanced provider by MediFind in the treatment of Brain Stem Cancer. He is also highly rated in 28 other conditions, according to our data. His clinical expertise encompasses Brain Aneurysm, Subarachnoid Hemorrhage, Acoustic Neuroma, Thrombectomy, and Gastrostomy.

Dr. Jason Heth attended The University of Iowa where he received his medical degree and also completed his residency in Neurosurgery. Dr. Heth then completed additional training in Skull Base Neurosurgery, completing a fellowship at the University of Arkansas for Medical Sciences. After completing his fellowship, he joined the faculty of the University of Michigan. Dr. Heth specializes in brain tumor treatment, including surgical removal, radiosurgery, and basic research. His primary areas of interest focus on gliomas, glioblastoma, brain metastasis, and meningiomas. He is also involved in medical student education and quality improvement programs at the University of Michigan. Dr. Heth is rated as an Advanced provider by MediFind in the treatment of Brain Stem Cancer. He is also highly rated in 33 other conditions, according to our data. His clinical expertise encompasses Glioblastoma, Astrocytoma, Brain Tumor, Awake Craniotomy, and Gastrostomy. Dr. Heth is board certified in Neurological Surgery.

Dr. Venkatakrishna Rajajee completed his medical training at the Madras Medical College in India. He completed his residency in Neurology at the Mount Sinai Medical Center, New York in 2003, followed by fellowships in Stroke/ Vascular Neurology and Neurological Critical Care at the UCLA Medical Center 2003-2005. In addition, he has several years of experience in private practice as an attending physician in medical/ surgical intensive care units. He joined the University of Michigan’s neurosurgery department 2008 as faculty neurointensivist and vascular neurologist. He has served as the medical director of neurocritical care since 2014 and as co-director of the comprehensive stroke center since 2017.Dr. Rajajee has had a clinical, educational, and research interest in critical care ultrasound since 2007. He is a diplomate of the National Board of Echocardiography. He has published several articles on optic nerve ultrasound and transcranial doppler in neurocritical care, and helped pioneer the use of real-time ultrasound guidance during bedside tracheostomy in 2011. Dr. Rajajee developed and directed the Neurocritical Care Society’s (NCS) annual critical care ultrasound workshop between 2012-2014, and has served on the Society of Critical Care Medicine’s (SCCM) Ultrasound Committee. He currently coordinates the University of Michigan’s multidisciplinary critical care ultrasound lecture series.His other interests include the monitoring and management of patients with severe Traumatic Brain Injury (TBI). In 2013, Michigan Medicine signed a memorandum of understanding on collaboration in research and education with the All India Institute of Medical Sciences (AIIMS), New Delhi, with TBI as a major focus. As part of this collaboration, Dr. Rajajee has received funding from the National Institutes of Health (NIH) to study techniques of intracranial pressure assessment applicable to low and middle income nations. He has also received funding from the Department of Defense (DoD) to evaluate noninvasive techniques to assess the brain following TBI.He is a former chair of the Neurocritical Care Society’s Guidelines Committee, and the GRADE methodologist of the NCS guidelines for neuroprognostication in neurocritical care. He is the first author of the 2023 Guidelines for Neuroprognostication in Comatose Adult Survivors of Cardiac Arrest. Dr. Rajajee is rated as an Advanced provider by MediFind in the treatment of Brain Stem Cancer. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Brain Herniation, Chiari Malformation Type 1, Chiari Malformation, Gastrostomy, and Transmyocardial Revascularization.

Nathan Clarke is a Neurologist practicing medicine in Ann Arbor, Michigan. He has been practicing medicine for over 10 years. Dr. Clarke is rated as an Advanced provider by MediFind in the treatment of Brain Stem Cancer. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Glioma, Astrocytoma, Brain Tumor, and Glioblastoma. Dr. Clarke is board certified in Neurology.

Michelle Kim, M.D. is an associate professor in the Department of Radiation Oncology at the University of Michigan. She completed her medical training at Case Western Reserve University and her residency at MD Anderson Cancer Center. Dr. Kim is board-certified in Radiation Oncology by the American Board of Radiology. Her research focus is in the adaptive individualization of radiation therapy using advanced molecular and functional imaging for patients with central nervous system tumors including gliomas and brain metastases. Dr. Kim is rated as an Advanced provider by MediFind in the treatment of Brain Stem Cancer. She is also highly rated in 30 other conditions, according to our data. Her clinical expertise encompasses Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), Metastatic Brain Tumor, and Astrocytoma. Dr. Kim is board certified in Radiation Oncology.

Dr. Leung is the Director of the Neuro-Oncology Fellowship Program and is a clinical assistant professor in the Department of Neurology. She sees patients in the Neuro-Oncology Clinic at the Rogel Cancer Center and at the Northville Health Center. She completed a bachelor’s degree at the University of Western Ontario, a master’s degree at the University of Toronto, and medical degree at SUNY Upstate. Dr. Leung completed her Neurology residency and Neuro-Oncology fellowship at Henry Ford Hospital. Dr. Leung is rated as an Advanced provider by MediFind in the treatment of Brain Stem Cancer. She is also highly rated in 26 other conditions, according to our data. Her clinical expertise encompasses Glioblastoma, Astrocytoma, Glioma, and Metastatic Brain Tumor. Dr. Leung is board certified in Neurology.

Ann Little is a Neurologist and a Neuroradiologist practicing medicine in Ann Arbor, Michigan. Dr. Little is rated as an Advanced provider by MediFind in the treatment of Brain Stem Cancer. She is also highly rated in 63 other conditions, according to our data. Her clinical expertise encompasses Inclusion Body Myositis, Polymyositis, Myasthenia Gravis, Stent Placement, and Transmyocardial Revascularization.

After completing his chief residency at the University of Virginia, Dr. Sagher accepted a position on the neurosurgical faculty at the University of Michigan. He became Chief of Neurosurgery at the Ann Arbor Veterans Administration Hospital, a position he held until 1996. He then completed a fellowship in Pain and Functional Neurosurgery at the Oregon Health Sciences University, and took over as the Director of Neuromodulation at the University of Michigan. As the primary functional neurosurgeon at the University of Michigan, Dr. Sagher takes care of such problems as epilepsy, pain, Parkinson's Disease and other movement disorders. Dr. Sagher is board certified by the American Board of Neurological Surgeons, and is a member of the American Association of Neurological Surgeons (AANS) and the Congress of Neurological Surgeons (CNS). He has served on the Executive Council on the AANS/CNS Joint Section on Pain, which he chaired from 2003 to 2005. Special Interests: The treatment of epilepsy, pain, movement disorders, and brain tumors in functionally important regions. Dr. Sagher is rated as an Advanced provider by MediFind in the treatment of Brain Stem Cancer. He is also highly rated in 37 other conditions, according to our data. His clinical expertise encompasses Trigeminal Neuralgia, Meningioma, Seizures, Awake Craniotomy, and Microvascular Decompression. Dr. Sagher is board certified in Neurological Surgery.